• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
Evoke Pharma released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 4.284 M (forecast USD 4.326 M), actual EPS USD -0.4521 (forecast USD -0.45)
04:00
Evoke Pharma released FY2025 9 Months Earnings on November 13 (EST), actual revenue USD 11.12 M, actual EPS USD -1.5798
04:00
Aug15
Evoke Pharma released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 3.752 M (forecast USD 3.796 M), actual EPS USD -0.62 (forecast USD -0.3)
03:00
Evoke Pharma released FY2025 Semi-Annual Earnings on August 14 EST, with actual revenue of USD 6.832 M and EPS of USD -1.1278
03:00
May22
Evoke Pharma Holds Annual Shareholders Meeting to Approve New Board Members
20:31
May14
Evoke Pharma released FY2025 Q1 earnings on May 13 (EST), actual revenue USD 3.08 M (forecast USD 3.316 M), actual EPS USD -0.5124 (forecast USD -0.33)
03:00

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.284 M, Net Income -1.156 M, EPS -0.4521

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.752 M, Net Income -1.571 M, EPS -0.6153

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 3.08 M, Net Income -1.306 M, EPS -0.5124

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More